Financial Performance - The company incurred a net loss of $2,693,100 for the nine months ended March 31, 2025, and a cumulative net loss of $40.5 million since its incorporation on November 14, 2017[92]. - Revenue for the three months ended March 31, 2025, was approximately $31,000, down from $34,000 for the same period in 2024, and revenue for the nine months ended March 31, 2025, was approximately $55,000 compared to $139,000 in 2024[112]. - The net loss for the three months ended March 31, 2025, was approximately $663,000, a decrease of about 53% compared to a net loss of approximately $1.4 million for the same period in 2024[123]. - For the nine months ended March 31, 2025, the net loss was approximately $2.7 million, which is about 16% lower than the $3.2 million loss for the same period in 2024[123]. Cash and Financing - As of March 31, 2025, the company's cash and cash equivalents totaled $2,858,963, an increase from $2,071,016 as of June 30, 2024[101][107]. - The company has raised net proceeds of approximately $11,760,000 from private placement financing transactions from its incorporation to September 30, 2020[97]. - The company has plans to generate cash through financing transactions, including offerings of common stock, but these plans are subject to market conditions and uncertainty[94][105]. Expenses - General and administrative expenses for the three months ended March 31, 2025, were approximately $428,000, a decrease from $1,135,000 in the same period in 2024[117]. - Technology and content development expenses for the nine months ended March 31, 2025, were approximately $524,000, down from $889,000 for the same period in 2024[119]. - Sales and marketing expenses for the three months ended March 31, 2025, were approximately $118,000, compared to $139,000 for the same period in 2024[121]. - Interest income for the nine months ended March 31, 2025, was approximately $53,000, down from $148,000 for the same period in 2024[122]. - Capital asset additions for the nine months ended March 31, 2025, were $292,200, compared to $228,000 for the same period in 2024, indicating an increase of approximately 28%[124]. Compliance and Internal Controls - The Company received a Nasdaq deficiency letter on November 26, 2024, due to non-compliance with the Stockholders' Equity Requirement of $2,500,000[125]. - On January 10, 2025, the Company submitted a plan to regain compliance and believed it had regained compliance following a public offering[126]. - The Company reported material weaknesses in its internal controls over financial reporting, which could lead to potential misstatements in financial statements[130][131]. - Management identified deficiencies in controls related to journal entries and stock compensation expense calculations[132]. - The Company plans to document processes and controls to address the identified material weaknesses and improve internal control effectiveness[136]. - There were no changes in internal control over financial reporting that materially affected the Company during the period ended March 31, 2025[135]. - The Company intends to take all reasonable measures to maintain compliance with Nasdaq Listing Rules[127]. Business Development - The company is focusing on developing AI-powered B2B and B2C solutions, with the NurseMagic app being a key product that has gained traction[114].

Core Insights - Amesite Inc. has launched a higher-priced enterprise tier, Teams Plus+, for its NurseMagic app, responding to increased demand from businesses for greater capacity and advanced analytics [1][2] - The new tier allows businesses to access real-time insights and productivity metrics, which are essential for improving efficiency and reducing costs [2][3] Company Overview - Amesite Inc. is focused on transforming the $330 billion home and healthcare segments with its AI-driven solutions [3] - NurseMagic significantly reduces documentation time for healthcare professionals from 20 minutes to just 20 seconds, enhancing operational efficiency and financial performance [3] - The platform complies with HIPAA regulations and is utilized by over 100 professions across 50 states and 21 countries, offering integration into healthcare workflows and multilingual support [3] Market Response - The introduction of Teams Plus+ is a direct response to B2B customer requests for more capacity, with positive reviews indicating strong market demand [2] - The company anticipates increased sales and customer retention as businesses scale their usage of NurseMagic [2] - The demand for enhanced services highlights the successful product adoption within just eight months of the B2B solution's public launch [2]

Core Insights - Amesite Inc. announced that its product NurseMagic™ now meets HIPAA requirements for all users, ensuring compliance for both individual and enterprise usage in handling sensitive healthcare information [1][2] - The company has reported increased sales in B2B following its earlier compliance with HIPAA for enterprise customers [1][4] Company Developments - NurseMagic™ provides a Business Associate Agreement (BAA) for all users, allowing care providers to securely enter patient details and personally identifiable health information (PHI) [2] - The application is designed to integrate seamlessly with existing electronic medical record (EMR) systems, enhancing its utility across various healthcare software infrastructures [2][6] Market Position and Growth - NurseMagic™ has gained traction in both B2B and B2C sales, with a growing user base and recurring revenue [4] - The healthcare software-as-a-service market is projected to exceed $90 billion by 2033, with a compound annual growth rate (CAGR) of nearly 11% [5] Product Impact - NurseMagic™ has been adopted by professionals in over 130 different roles, demonstrating its effectiveness in improving care delivery and operational efficiency [3][6] - The product significantly reduces documentation time for healthcare workers from 20 minutes to just 20 seconds, enhancing overall productivity [6]

Core Insights - Amesite Inc. remains insulated from U.S. trade uncertainties due to its fully remote, U.S.-based workforce and lack of reliance on foreign suppliers [1][2] - The company’s flagship product, NurseMagic™, significantly reduces documentation time for healthcare professionals, enhancing operational efficiency and financial performance [3][4] Company Operations - Amesite operates with a cloud-native infrastructure that avoids international chokepoints, protecting it from tariff impacts [1] - The company is focused on transforming the $330 billion home and healthcare segments with its AI-driven solutions [4] Product Performance - NurseMagic™ reduces charting time from 20 minutes to just 20 seconds, making it a high-performing and cost-effective solution for users [4] - The platform is currently being adopted by larger organizations across clinical and non-clinical teams, driving user growth and revenue [3] Market Position - The demand for NurseMagic™ is increasing due to rising cost pressures in the healthcare industry, positioning Amesite as a leader in the home health sector [3] - The platform serves B2B and B2C users across 50 states and 21 countries, with capabilities for seamless integration into healthcare workflows [4]

Core Insights - Amesite Inc. has launched its non-clinical caregiver tool, NurseMagic™, aimed at enhancing the efficiency of non-clinical healthcare workers [1] - The company has significantly expanded its addressable market for enterprise sales by approximately 50% by focusing on non-clinical staff in home health care and skilled nursing sectors [2] - There has been a dramatic increase in contract adoption and sizes, with hospice provider contracts growing over 3,000% and contract sizes increasing nearly 1,000% in the last three months [3] Company Overview - Amesite is an AI-driven company targeting the $330 billion home and healthcare market, with its flagship product, NurseMagic™, designed to streamline documentation for caregivers, reducing time from 20 minutes to just 20 seconds [5] - The platform is utilized by over 100 professions and is compliant with HIPAA regulations, enhancing operational efficiency and financial performance [5] - NurseMagic™ offers seamless integration into healthcare workflows and supports translations in over 50 languages, serving B2B and B2C users across 50 states and 21 countries [5] Market Dynamics - The U.S. has nearly 3 million home health care and skilled nursing staff, with over 1.5 million being non-clinical healthcare support workers, indicating a substantial market for Amesite's solutions [2] - The company is experiencing accelerated contract closures and increasing deal sizes, providing a competitive advantage to organizations that deploy its platform across their entire workforce [4] - Amesite plans to introduce several new tools in the coming months, driven by customer engagement and market needs [4]

Core Insights - Amesite Inc. has successfully adopted its hospice documentation tool, NurseMagic™, addressing the critical issue of proper documentation in hospice care, which is essential for reimbursement [1] - The hospice care segment is experiencing rapid growth, with a reported 4.61% CAGR, and is projected to increase from $31.21 billion to $39.09 billion by 2030, highlighting the need for improved documentation solutions [4] Company Developments - Over the last three months, deal sizes with hospice providers have surged by nearly 1,000%, and NurseMagic™ sales have increased by over 3,000% as the company ramps up enterprise sales nationally [2][3] - The company has expanded its capabilities to support entire care teams, including nurses and non-clinical staff, enhancing the efficiency of hospice care documentation [3] Market Context - End-of-life care currently accounts for 21% of a person's lifetime healthcare costs, emphasizing the importance of hospice care in improving healthcare efficiency and patient satisfaction [3] - The rapid consumer acceptance of hospice care underscores the growing demand for effective documentation tools, which are critical for the segment's growth [4] Product Features - NurseMagic™ significantly reduces documentation time from 20 minutes to just 20 seconds, improving operational efficiency and financial performance for healthcare providers [5] - The platform is designed to meet HIPAA regulations while providing seamless integration into healthcare workflows, serving B2B and B2C users across 50 states and 21 countries [5]

Core Insights - Amesite Inc. has successfully adopted its hospice documentation tool, NurseMagic™, which addresses the critical issue of proper documentation in hospice care, reducing the risk of unreimbursed charges [1] - The company has experienced a significant increase in deal sizes with hospice providers, growing nearly 1,000% over the last three months, and is now securing entire workforces with its tools [2] - NurseMagic™ sales have surged by over 3,000% in the same period, indicating strong market demand and the effectiveness of the company's enterprise sales strategy [3] Company Developments - The hospice care segment is rapidly growing, currently valued at $31.21 billion and projected to reach $39.09 billion by 2030, with a compound annual growth rate (CAGR) of 4.61% [4] - Amesite's NurseMagic™ significantly reduces documentation time from 20 minutes to just 20 seconds, enhancing operational efficiency for healthcare professionals [5] - The company is expanding its capabilities in the healthcare sector, focusing on larger organizations and utilizing data from a large group of professionals to inform its technology and sales strategies [3][4] Market Context - End-of-life care accounts for 21% of a person's lifetime healthcare costs, highlighting the importance of hospice care in improving healthcare efficiency and patient satisfaction [3] - The demand for improved documentation in hospice care is critical for the segment's growth, as it directly impacts reimbursement and compliance [4]

Core Insights - Amesite Inc. has successfully implemented an automated sales process for its NurseMagic™ enterprise solution, significantly reducing the time to close sales by over 95% [1][5][6] Company Overview - Amesite Inc. specializes in AI-driven solutions for B2C and B2B markets, focusing on the healthcare sector with its flagship product, NurseMagic™ [1][9] - The company aims to transform the $360 billion home, hospice, and healthcare segments, with a long-term vision of a $600 billion opportunity for AI transformation by 2034 [2][8][9] Product Features - NurseMagic™ is designed to reduce documentation burdens, enhance patient communication, and improve workflow efficiency for healthcare professionals [4][9] - The platform allows enterprise customers to initiate and complete subscriptions in minutes, facilitating immediate onboarding and reducing operational risks [3][7] Market Potential - The addressable market for NurseMagic™ spans over 50,000 U.S. businesses across home care, home health care, and hospice sectors, representing a significant growth opportunity [2][6] - As demand for home-based care rises, healthcare organizations are increasingly seeking solutions that streamline operations while maintaining high-quality patient care [6] Sales and Onboarding Efficiency - The automated sales flow enables healthcare organizations to onboard employees onto the NurseMagic™ app quickly, ensuring efficiency gains are realized immediately [5][6] - Customers can easily manage and scale their NurseMagic™ subscriptions, adding licenses as their teams grow [3][5]

Financial Performance - The company incurred a net loss of $2,029,682 for the six months ended December 31, 2024, and a cumulative net loss of $39.9 million since its incorporation on November 14, 2017[91][96]. - Revenue for the six months ended December 31, 2024, was approximately $24,000, a significant decrease from $105,000 for the same period in 2023[114]. - Interest income for the six months ended December 31, 2024, was approximately $28,500, compared to $110,000 for the same period in 2023[124]. - One customer accounted for approximately 94% of total revenue for the six months ended December 31, 2024[112]. Cash and Financing - As of December 31, 2024, the company's cash and cash equivalents totaled $519,706, down from $2,071,016 as of June 30, 2024[107]. - The company has raised approximately $11,760,000 from private placement financing transactions since its inception, with a public offering on January 8, 2025, generating approximately $3.08 million in cash proceeds[97][100]. Expenses - General and administrative expenses increased to approximately $1,438,000 for the six months ended December 31, 2024, compared to approximately $882,000 for the same period in 2023[119]. - Technology and content development expenses decreased to approximately $352,000 for the six months ended December 31, 2024, from approximately $664,000 in the same period in 2023[121]. - Sales and marketing expenses were approximately $293,000 for the six months ended December 31, 2024, down from approximately $464,000 for the same period in 2023[123]. - Capital asset additions for the six months ended December 31, 2024, were $212,600, compared to $118,000 in the same period of 2023, indicating a significant increase in capital expenditures[126]. Compliance and Regulatory Issues - The Company received a Nasdaq deficiency letter on November 26, 2024, due to non-compliance with the Stockholders' Equity Requirement of $2,500,000[127]. - The Company submitted a plan to regain compliance on January 10, 2025, and believes it has regained compliance following a public offering[128]. - Nasdaq confirmed compliance with the Stockholders' Equity Requirement on January 23, 2025, but warned of potential delisting if compliance is not evidenced in the next periodic report[128]. Internal Controls - Management concluded that disclosure controls and procedures were not effective due to identified material weaknesses in internal control over financial reporting[132]. - Specific material weaknesses included deficiencies in reviewing and approving journal entries and ensuring accurate stock compensation expense calculations[134]. - The Company is taking steps to remediate material weaknesses, including documenting processes and controls for business transactions[138]. - There were no changes in internal control over financial reporting that materially affected the Company's controls during the period ended December 31, 2024[137]. - The Company plans to formalize processes for monitoring internal control over financial reporting to improve overall effectiveness[138]. - There is no assurance that current or planned remediation measures will be sufficient to address identified material weaknesses[136]. Going Concern - The company has substantial doubt about its ability to continue as a going concern due to ongoing net losses and negative cash flows[92][105].

Company Overview - Amesite, Inc. is a pioneering technology company specializing in B2C and B2B AI-driven solutions, with a focus on developing applications that enhance efficiency and reduce costs in various sectors [3] - The company has launched NurseMagic™, an AI-powered application designed specifically for nursing professionals and home health care workers, which streamlines documentation and enhances patient communication [3] Product Details - NurseMagic™ has seen rapid adoption, with users across all fifty U.S. states and twenty-one countries, indicating strong market penetration [2] - The application offers a suite of tools for nursing professionals, including the ability to create nursing notes in multiple formats such as SOAP, SOAPIER, Narrative, and ISBAR within seconds [2] - Testimonials from paying customers validate the product's market fit and its effectiveness as a gamechanger in the healthcare sector [2] Market Context - The healthcare sector targeted by NurseMagic™ is valued at approximately $130 billion, presenting significant growth opportunities for the company [2] - The company aims to deliver value to both business owners and employees within this sector through its innovative solutions [2]